Brainsway (BWAY) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
BrainsWay reported a strong 26% revenue growth in Q3 2024, raising its full-year revenue guidance to $40-41 million and achieving net income of $0.7 million. The company plans to leverage a recent $20 million equity financing for strategic initiatives and market expansion. BrainsWay continues to advance its Deep TMS technology, with increased system deployments and ongoing clinical trials, enhancing its leadership in mental health treatment innovations.
For further insights into BWAY stock, check out TipRanks’ Stock Analysis page.
